APA (7th ed.) Citation

ZJ, X., Y, J., XL, Z., PH, X., XM, W., JC, M., . . . J, Q. (2023). Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia. Cancer medicine, 12(1), 789. https://doi.org/10.1002/cam4.4905

Chicago Style (17th ed.) Citation

ZJ, Xu, Jin Y, Zhang XL, Xia PH, Wen XM, Ma JC, Lin J, and Qian J. "Pan-cancer Analysis Identifies CD300 Molecules as Potential Immune Regulators and Promising Therapeutic Targets in Acute Myeloid Leukemia." Cancer Medicine 12, no. 1 (2023): 789. https://doi.org/10.1002/cam4.4905.

MLA (9th ed.) Citation

ZJ, Xu, et al. "Pan-cancer Analysis Identifies CD300 Molecules as Potential Immune Regulators and Promising Therapeutic Targets in Acute Myeloid Leukemia." Cancer Medicine, vol. 12, no. 1, 2023, p. 789, https://doi.org/10.1002/cam4.4905.